A single-center experience of antimicrobial resistance patterns in pediatric urinary tract infection

Medical Principles and Practice

Volumn 19, Issue 5, 2010, Pages 359-363

  Senel, Saliha ^a,b   Karacan, Candemir ^a   Erkek, Nilgun ^a   Gol, Nese ^b  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b Dr Sami Ulus Children's Health and Diseases Training and Research Hospital   (Turkey)

Author keywords

Antimicrobial resistance; Pediatric infections; Resistance patterns; Susceptibility testing; Urinary tract infection; Uropathogens

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMOXICILLIN PLUS SULBACTAM; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN; SULBACTAM; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; NONHUMAN; PRESCHOOL CHILD; PROTEUS MIRABILIS; PSEUDOMONAS; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; URINE CULTURE; VANCOMYCIN RESISTANT ENTEROCOCCUS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PREVALENCE; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 77954801050     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316373     Document Type: Article

References (21)

1. Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R: Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Med Princ Pract 2004; 13: 334-339.
2. Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N: Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures. Jpn J Infect Dis 2006; 59: 380-382.
3. Erb A, Stürmer T, Marre R, Brenner H: Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 2007; 26: 83-90.
4. Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E: Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006. Int Urol Nephrol 2008, E-pub ahead of print.
5. Goldraich NP, Manfroi A: Febrile urinary tract infection: Escherichia coli susceptibility to oral antimicrobials. Pediatr Nephrol 2002; 17: 173-176.
6. Guidoni EB, Berezin EN, Nigro S, Santiago NA, Benini V, Toporovski J: Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis 2008; 12: 321-323.
7. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing. Twelfth Informational Supplement. NCCLS document M100-S12. Wayne, National Committee for Clinical Laboratory Standards, 2002.
8. Wiswell TE: The prepuce, urinary tract infections, and the consequences. Pediatrics 2000; 105: 860-862.
9. Wolff O, Maclennan C: Evidence behind the WHO guidelines: hospital care for children: what is the appropriate empiric antimicrobial agent therapy in uncomplicated urinary tract infections in children in developing countries? J Trop Pediatr 2007; 53: 150-152.
10. Gökçe I, Alpay H, Biyikli N, Ozdemir N: Urinary tract pathogens and their antimicrobial resistance patterns in Turkish children. Pediatr Nephrol 2006; 21: 1327-1328.
11. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB: Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol 2008; 23: 597-602.
12. Mårild S, Jodal U, Sandberg T: Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. Pediatr Nephrol 2009; 24: 521-526.
13. Tseng MH, Lo WT, Lin WJ, Teng CS, Chu ML, Wang CC: Changing trend in antimicrobial resistance of pediatric uropathogens in Taiwan. Pediatr Int 2008; 50: 797-800.
14. Al-Mardeni RI, Batarseh A, Omaish L, Shraideh M, Batarseh B, Unis N: Empirical treatment for pediatric urinary tract infection and resistance patterns of uropathogens, in Queen Alia Hospital and Prince A'isha Military Center - Jordan. Saudi J Kidney Dis Transpl 2009; 20: 135-139.
15. Akram M, Shahid M, Khan AU: Etiology and antimicrobial agent resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6: 4.
16. Hodson EM, Willis NS, Craig JC: Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev 2007; 4:CD003772.
17. Gupta K: Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17: 243-259.
18. Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, Klugman KP, Courvalin P: The battle against emerging antimicrobial agent resistance: should fluoroquinolones be used to treat children? Clin Infect Dis 2002; 35: 721-727.
19. Santo E, Salvador MM, Marin JM: Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirão Preto, São Paulo, Brazil. Braz J Infect Dis 2007; 11: 575-578.
20. Patterson JE: Extended spectrum beta-lactamases: a therapeutic dilemma. Pediatr Infect Dis J 2002; 21: 957-959.
21. Borsari AG, Bucher B, Brazzola P, Simonetti GD, Dolina M, Bianchetti MG: Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland. Clin Ther 2008; 30: 2090-2095.